The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection With the Aim of Accelerating Diagnosis
October 17, 2019
October 17, 2019
PRINCETON, New Jersey, Oct. 17 -- Pfizer, a pharmaceutical company, issued the following news release:
PRINCETON, N.J., NEW YORK, N.Y. and SAN FRANCISCO, C.A., - The Bristol-Myers Squibb-Pfizer Alliance and Fitbit today announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib) with the aim of improving earlier detection in individuals at increased risk of stroke. The BMS-Pfizer Alliance and Fitbit . . .
PRINCETON, N.J., NEW YORK, N.Y. and SAN FRANCISCO, C.A., - The Bristol-Myers Squibb-Pfizer Alliance and Fitbit today announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib) with the aim of improving earlier detection in individuals at increased risk of stroke. The BMS-Pfizer Alliance and Fitbit . . .